CAPTRUST Financial Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,333
| Closed | -$8.14K | – | 2370 |
|
|
2024
Q2 | $8.14K | Sell |
12,333
-3
| -0% | -$2 | ﹤0.01% | 2189 |
|
|
2024
Q1 | $7.43K | Sell |
12,336
-7
| -0.1% | -$4 | ﹤0.01% | 2128 |
|
|
2023
Q4 | $7.25K | Sell |
12,343
-5,525
| -31% | -$3.32K | ﹤0.01% | 2640 |
|
|
2023
Q3 | $11.9K | Sell |
17,868
-38
| -0.2% | -$47 | ﹤0.01% | 2535 |
|
|
2023
Q2 | $58.9K | Buy |
17,906
+35
| +0.2% | +$106 | ﹤0.01% | 2420 |
|
|
2023
Q1 | $162K | Sell |
17,871
-266
| -1% | -$3.77K | ﹤0.01% | 2092 |
|
|
2022
Q4 | $213K | Sell |
18,137
-1,924
| -10% | -$33.9K | ﹤0.01% | 1911 |
|
|
2022
Q3 | $425K | Buy |
20,061
+20,060
| +2,006,000% | +$541K | ﹤0.01% | 1322 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 5195 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5191 |
|
|
2021
Q4 | $0 | Sell |
1
-3,832
| -100% | -$323K | ﹤0.01% | 4960 |
|
|
2021
Q3 | $358K | Hold |
3,833
| – | – | ﹤0.01% | 1199 |
|
|
2021
Q2 | $385K | Hold |
3,833
| – | – | ﹤0.01% | 1113 |
|
|
2021
Q1 | $358K | Hold |
3,833
| – | – | ﹤0.01% | 1137 |
|
|
2020
Q4 | $316K | Buy |
3,833
+3,826
| +54,657% | +$326K | ﹤0.01% | 1005 |
|
|
2020
Q3 | $1K | Buy |
+7
| New | +$816 | ﹤0.01% | 2972 |
|
CAPTRUST Financial Advisors's VBIV Position: Q3 2024 in Review
CAPTRUST Financial Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 12,333 shares — an estimated $8.14K sold.
CAPTRUST Financial Advisors first reported a position in VBIV in Q3 2020 and held it in 16 quarters. The position peaked at $425K in Q3 2022. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- CAPTRUST Financial Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 12,333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $8.14K.
- CAPTRUST Financial Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 16 quarters.
- CAPTRUST Financial Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $425K in Q3 2022.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.